793 results on '"Borrow R"'
Search Results
102. Impact of the 7-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Infants Younger Than 90 Days in England and Wales
103. Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009
104. Structure of a complex between CCPs 6 and 7 of Human Complement Factor H and Neisseria meningitidis FHbp Variant 3 P106A mutant
105. Structure of a complex between CCPs 6 and 7 of Human Complement Factor H and Neisseria meningitidis FHbp Variant 1 E283AE304A mutant
106. Structure of a complex between CCPs 6 and 7 of Human Complement Factor H and Neisseria meningitidis FHbp Variant 1 R106A mutant
107. Structure of the C-terminal barrel of Neisseria meningitidis FHbp Variant 2
108. Structure of a complex between CCPs 6 and 7 of Human Complement Factor H and Neisseria meningitidis FHbp Variant 3 Wild type
109. The Global Meningococcal Initiative (GMI): efforts to prevent and control meningococcal disease in India
110. Vaccination in paediatric patients with auto-immune rheumatic diseases: A systemic literature review for the European League against Rheumatism evidence-based recommendations
111. Bacterial Genomic Detection Within Cerebrospinal Fluid of Patients With Meningococcal Disease Is Influenced by Microbial and Host Characteristics
112. Serum Antibody Kinetics following Nasal or Parenteral Challenge with Meningococcal Polysaccharide in Healthy Adults
113. Commentary on ‘Combined DTP‐HBV‐HIB vaccine versus separately administered DTP‐HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)’
114. Immunisation of immunocompromised children against pneumococcus: which vaccine should now be used?: Abstract G164 Table 1
115. Immunogenicity of a Heptavalent Conjugate Pneumococcal Vaccine Administered Concurrently with a Combination Diphtheria, Tetanus, Five-Component Acellular Pertussis, Inactivated Polio, and Haemophilus influenzae Type b Vaccine and a Meningococcal Group C Conjugate Vaccine at 2, 3, and 4 Months of Age
116. Investigation of Different Group A Immunoassays following One Dose of Meningococcal Group A Conjugate Vaccine or A/C Polysaccharide Vaccine in Adults
117. Competitive Inhibition Flow Analysis Assay for the Non-Culture-Based Detection and Serotyping of Pneumococcal Capsular Polysaccharide
118. Failure of antibody response to polysaccharide antigen in treated adult panhypopituitary adults
119. Pilot study of human experimental challenge with neisseria lactamica
120. Erratum: Prevalence of human papillomavirus antibodies in young female subjects in England
121. Mode of splenectomy and immunogenicity of meningococcal vaccination in patients with hereditary spherocytosis
122. Prevalence of human papillomavirus antibodies in young female subjects in England
123. P1215 Endemic serogroup W135 meningococcal meningitis possibly originated from 2000 and 2001 Hajj epidemics: a prospective study for the aetiology of childhood acute bacterial meningitis in Turkey
124. Revaccination of Children after Completion of Standard Chemotherapy for Acute Leukemia
125. P1086 Serum bactericidal antibody titres against serogroup C meningococci in Turkish children: serological basis of the need for conjugated meningococcal vaccine
126. Revaccination with Measles, Tetanus, Poliovirus, Haemophilus influenzae Type B, Meningococcus C, and Pneumococcus Vaccines in Children after Hematopoietic Stem Cell Transplantation
127. Genetic Polymorphism of the Binding Domain of Surfactant Protein-A2 Increases Susceptibility to Meningococcal Disease
128. Anti-pneumococcal antibody titre measurement: what useful information does it yield?
129. Neisseria meningitidis group B correlates of protection and assay standardization—International Meeting Report Emory University, Atlanta, Georgia, United States, 16–17 March 2005
130. Immunogenicity of Meningococcal ACYW135 Polysaccharide Vaccine in Saudi Children 5 to 9 Years of Age
131. Serologic Responses to ACYW135 Polysaccharide Meningococcal Vaccine in Saudi Children under 5 Years of Age
132. Response of dexamethasone treated former preterm infants to a single dose of meningococcal c conjugate vaccine
133. Meningococcal surrogates of protection?serum bactericidal antibody activity
134. Meningococcal infection in England and Wales: 1999–2001
135. Non-culture based characterisation of Neisseria meningitidis to guide public health interventions and vaccine development
136. Meningococcal C conjugate vaccines in children and adolescents: The effect of prior, concurrent or subsequent administration of DT vaccine
137. Meningococcal outer membrane vesicle (OMV) antibody avidity indices as a surrogate marker of priming for the induction of immunological memory following vaccination with a meningococcal hexavalent PorA OMV vaccine
138. Meningococcal serogroup a avidity indices as a surrogate marker of priming for the induction of immunological memory following vaccination with a meningococcal A/C conjugate vaccine in infants
139. Genotyping of Enterocytozoon bieneusi in AIDS Patients from the North West of England
140. Simultaneous Detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in Suspected Cases of Meningitis and Septicemia Using Real-Time PCR
141. Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults
142. Contamination and Sensitivity Issues with a Real-Time Universal 16S rRNA PCR
143. Clinical Features, Laboratory Findings and Management of Meningococcal Meningitis in England and Wales: Report of a 1997 Survey
144. Optimising laboratory ascertainment of meningococcal disease by non-culture case confirmation using serodiagnosis PCR and improved latex agglutination methods
145. Death in meningococcal disease and polymorphisms of pro-inflammatory cytokine genes
146. Subtyping of methicillin-resistant Staphylococcus aureus isolates from the North-West of England: a comparison of standardised pulsed-field gel electrophoresis with bacteriophage typing including an inter-laboratory reproducibility study
147. The BBN/HARC Spoken Language system
148. Design and Performance of HARC, the BBN Spoken Language Understanding System
149. The immune response to a meningococcal 200 kDa surface exposed protein following carriage and disease
150. Conjugate Meningococcal Serogroup A and C Vaccine: Reactogenicity and Immunogenicity in United Kingdom Infants
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.